SE8804640L - MEDICINAL COMPREHENSIVE CYCLOLINOPEPTIDE A - Google Patents

MEDICINAL COMPREHENSIVE CYCLOLINOPEPTIDE A

Info

Publication number
SE8804640L
SE8804640L SE8804640A SE8804640A SE8804640L SE 8804640 L SE8804640 L SE 8804640L SE 8804640 A SE8804640 A SE 8804640A SE 8804640 A SE8804640 A SE 8804640A SE 8804640 L SE8804640 L SE 8804640L
Authority
SE
Sweden
Prior art keywords
cyclolinopeptide
disclosed
mammal
medicinal
comprehensive
Prior art date
Application number
SE8804640A
Other languages
Unknown language ( )
Swedish (sv)
Other versions
SE8804640D0 (en
Inventor
Z Wieczorek
Original Assignee
Ferring Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Ab filed Critical Ferring Ab
Priority to SE8804640A priority Critical patent/SE8804640L/en
Publication of SE8804640D0 publication Critical patent/SE8804640D0/en
Priority to AU48177/90A priority patent/AU4817790A/en
Priority to PCT/SE1989/000732 priority patent/WO1990007523A1/en
Priority to KR1019900701862A priority patent/KR910700263A/en
Priority to CA002006383A priority patent/CA2006383A1/en
Publication of SE8804640L publication Critical patent/SE8804640L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids

Abstract

Cyclolinopeptide A having formula (I) for use as an immunosuppressive agent is disclosed. Furthermore, the use of Cyclolinopeptide A for the preparation of a medicament for immunosuppressive treatment, and a method of treating a mammal, including man, in need of immunosuppressive treatment comprising administering to said mammal a pharmacologically effective amount of Cyclolinopeptide A, are disclosed. Disclosed is also a pharmaceutical preparation comprising Cyclolinopeptide A, together with pharmaceutically acceptable carrier(s), excipient(s) and/or diluent(s).
SE8804640A 1988-12-23 1988-12-23 MEDICINAL COMPREHENSIVE CYCLOLINOPEPTIDE A SE8804640L (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE8804640A SE8804640L (en) 1988-12-23 1988-12-23 MEDICINAL COMPREHENSIVE CYCLOLINOPEPTIDE A
AU48177/90A AU4817790A (en) 1988-12-23 1989-12-15 Medicament comprising cyclolinopeptide a
PCT/SE1989/000732 WO1990007523A1 (en) 1988-12-23 1989-12-15 Medicament comprising cyclolinopeptide a
KR1019900701862A KR910700263A (en) 1988-12-23 1989-12-15 Medicines containing cyclolinopeptides
CA002006383A CA2006383A1 (en) 1988-12-23 1989-12-21 Medicament comprising cyclolinopeptide a

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8804640A SE8804640L (en) 1988-12-23 1988-12-23 MEDICINAL COMPREHENSIVE CYCLOLINOPEPTIDE A

Publications (2)

Publication Number Publication Date
SE8804640D0 SE8804640D0 (en) 1988-12-23
SE8804640L true SE8804640L (en) 1990-06-24

Family

ID=20374319

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8804640A SE8804640L (en) 1988-12-23 1988-12-23 MEDICINAL COMPREHENSIVE CYCLOLINOPEPTIDE A

Country Status (5)

Country Link
KR (1) KR910700263A (en)
AU (1) AU4817790A (en)
CA (1) CA2006383A1 (en)
SE (1) SE8804640L (en)
WO (1) WO1990007523A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE467410B (en) * 1990-09-25 1992-07-13 Ferring Ab ANALOGS OF CYCLOLINOPEPTIDE AND USE THEREOF
US20110104186A1 (en) 2004-06-24 2011-05-05 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
EP2229403B1 (en) * 2007-12-21 2013-10-16 University of Saskatchewan Recovery of hydrophobic peptides from oils
CA2859827A1 (en) * 2011-12-19 2013-06-27 Bernard Laarveld Use of cyclic peptides from flaxseed for improving animal and human health
FR3077202B1 (en) 2018-02-01 2020-01-10 Sederma USE OF CYCLOPEPTIDES IN COSMETICS

Also Published As

Publication number Publication date
AU4817790A (en) 1990-08-01
SE8804640D0 (en) 1988-12-23
KR910700263A (en) 1991-03-14
WO1990007523A1 (en) 1990-07-12
CA2006383A1 (en) 1990-06-23

Similar Documents

Publication Publication Date Title
ATE113203T1 (en) PHARMACEUTICAL FORM FOR ADMINISTRATION OF AN ANTIPARKINSONIC AGENT.
DK77090A (en) Immunomodulatory AZASPIRANS
BR9306841A (en) Pharmaceutical composition process for providing an antihistamine treatment which does not induce any significant cardiac arrhythmia in a human patient and use of a composition for the manufacture of a medicine for use in an antihistamine treatment
KR930702022A (en) Treatment or prevention of type 1 diabetes by oral administration of insulin
MX171191B (en) PHARMACEUTICAL COMPOSITIONS OF GLIPIZIDE
EP1014996A4 (en) Specific saccharide compositions and methods for treating alzheimer's disease and other amyloidoses
MX9203543A (en) MEDICINE.
HUT60630A (en) Process or producing peroral pharmaceutical compositions suitable for treating internal diseases of inflammatory nature
EP0484112A3 (en) Use of lithium in the treatment or prophylaxis of molluscum contagiosum
KR910005858A (en) Fatty acid therapy
SE8804640L (en) MEDICINAL COMPREHENSIVE CYCLOLINOPEPTIDE A
SE8903117D0 (en) MEDICINAL COMPREHENSIVE ANTAMANIDE
KR930003913A (en) Methods and pharmaceutical compositions for enhancing the antitussive effect of dextromethorphan
NO993921D0 (en) Medication for infertility and for increased fertility
KR870010871A (en) Intraoperative Treatment of Basal Cell Carcinoma by Recombinant Human Alpha Interferon
ATE178800T1 (en) PHARMACEUTICAL PENTAPEPTIDE COMPOSITION AND USE THEREOF
SE9003040D0 (en) ANALOGUES OF CYCLOLINOPEPTIDE AND THE USE THEREOF
NO961180L (en) Transdermal device containing (E) -2- (p-fluorophenethyl) -3-fluoroallylamine for the treatment of Alzheimer's disease
GB2019720A (en) S-adenosyl-L-homocysteine and salts thereof for use in therapy
CO5160246A1 (en) METHOD FOR THE PREVENTION OR REDUCTION OF CARDIOVASCULAR EPISODES ASSOCIATED WITH CORONARY INTERVENTIONS
AU4918900A (en) Interferon-beta use in the treatment of ewing's family of tumors
IT1243368B (en) Use of bendazac and of its pharmaceutically acceptable salts

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8804640-4

Effective date: 19920701